A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states.
about
Cross-national agreement on disability weights: the European Disability Weights ProjectExclusion Criteria in National Health State Valuation Studies: A Systematic Review.Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN).The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study.HEE-GER: a systematic review of German economic evaluations of health care published 1990-2004The SITLESS project: exercise referral schemes enhanced by self-management strategies to battle sedentary behaviour in older adults: study protocol for a randomised controlled trial.The social burden and quality of life of patients with haemophilia in Italy.Health-related quality of life in vacuum-assisted breast biopsy: short-term effects, long-term effects and predictors.Health related quality of life of Canary Island citizens.Utility scores for different health states related to depression: individual participant data analysis.Comparison of EQ-5D-5L health state utilities using four country-specific tariffs on a breast cancer patient sample in mainland China.International comparison of experience-based health state values at the population level.Health-related quality of life changes associated with buprenorphine treatment for opioid dependence.Outpatient Thermachoice endometrial balloon ablation: long-term, prognostic and quality-of-life measures.Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systemsComparison between EQ-5D and SF-6D utility in rural residents of Jiangsu Province, ChinaCost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.Measuring preferences for cost-utility analysis: how choice of method may influence decision-makingCompliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA studyComparing EQ-5D valuation studies: a systematic review and methodological reporting checklist.Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease.Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets.A pilot Internet "value of health" panel: recruitment, participation and compliance.Efficacy of low-intensity psychological intervention applied by ICTs for the treatment of depression in primary care: a controlled trialReview of disability weight studies: comparison of methodological choices and valuesModelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain.Differences in utility scores obtained through Brazilian and UK value sets: a cross-sectional study.Systematic review of the cost-effectiveness of implementing guidelines on low back pain management in primary care: is transferability to other countries possible?Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores?Broader conceptualization of remission assessed by the remission from depression questionnaire and its association with symptomatic remission: a prospective, multicenter, observational study.Medication-related factors associated with health-related quality of life in patients older than 65 years with polypharmacy.Adjustment of foreign EQ-5D-3L utilities can increase their transferability.Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancerAssessing disability weights based on the responses of 30,660 people from four European countries.Improving valuation sampling of EQ-5D health states.Valuing health in a racially and ethnically diverse community sample: an analysis using the valuation metrics of money and timeA comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes.The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy.A comparison of EuroQol 5-Dimension health-related utilities using Italian, UK, and US preference weights in a patient sample.Dealing with the health state 'dead' when using discrete choice experiments to obtain values for EQ-5D-5L heath states
P2860
Q24806917-CFB87EBB-526D-4956-A941-F33A056A4490Q30252110-FE1076E6-286E-418C-9B9A-FD4A257C89D2Q30608673-B8B886C1-3D65-4CAF-972C-3FD535E6DA06Q30982366-24035B65-1EEA-4BB9-BA57-A6CAB8874E18Q33269184-EABCED5D-ECE0-4CAA-9432-8AF367092858Q33705908-EB224608-1743-4284-A674-2D1ACFE53523Q33708947-F595D95B-DA2E-4CC3-91B8-EB298C3EF1E6Q33715855-2BB740CC-1901-40D8-A212-A8BF4F405689Q33739925-63C6DAFF-B419-40F9-81C2-1007CA5054D6Q33841729-746680D8-AC79-491D-BA7C-5C81C007F7CFQ33865239-8FF251FB-5D57-4DEC-BF86-DE1CDA9719E7Q33883700-C6A58E7E-D6F7-4BBE-BAD8-83AEDF5BF4AFQ34129263-97E59AD0-1D35-4454-88FB-513CD4EACD4FQ34153993-2A9F8AEC-67D0-410A-AC0C-EAB039711918Q34235044-F5ABF133-FB59-4D23-B784-29F6AB5EA496Q34358609-C3716118-D8AE-4575-B31C-BE170F736C1BQ34374726-30139B50-BAC1-46A4-8C31-89D58B8F35FAQ34614168-199E3184-5F4E-446E-9561-EFC476D56D3BQ34632976-2EB51405-CB62-4069-89BE-0E03C404BFF8Q34633630-FB873791-BE71-433A-9D8B-89E60A00279BQ35111195-A6E32B6C-B4B7-465C-9BFE-C2A11CA4F665Q35137275-BA2272DC-5B63-40D4-8B62-10CC7A48A32FQ35253313-5DEFFA11-96AA-40A8-B929-74C9C1B27FFBQ35599175-C0E71204-03A4-40CB-931B-DB8318EB00A6Q35653593-B29D3EA2-1B93-4E92-8D89-97FF072FD79FQ35878722-611BB14F-91A4-4D42-8D64-0AA01CC611A1Q35923254-D9C3ED3C-3D04-47DD-8A95-EBAF1935F61CQ36042117-9DC2E311-20B2-470F-B4F7-6FFDED6E22E3Q36127240-7B59C652-DE9B-462A-9A5B-10E0406DDD95Q36168261-BFA9BCDA-1669-41A6-9657-9344A39581A3Q36271696-3CFCBE94-969F-4A71-B72A-F6B0EC408EB9Q36394534-D108254C-BC6E-4506-B208-9C48082553B2Q36394607-2266B55C-9FBF-4A0C-804B-99FC22C9FBA2Q36469141-48FF466A-2C2C-4407-9665-3261298B2E2CQ36650886-CB8D8484-14FB-42FD-9FAC-0E6B32863C27Q36682279-6A3EC817-4E1D-4512-A7EE-8F0CF3B194CCQ36919790-2F0BDAB0-70A6-44EB-A8D6-9E92B81EA00EQ36940942-0F70779F-58E9-48CC-BE6D-34E6E89B7A8EQ37016870-D5F3163A-5302-4331-9FCD-4739301786BEQ37057599-EA78F6E7-2827-4766-83C4-2F50CE1E188B
P2860
A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A comparison of United Kingdom ...... alues for EQ-5D health states.
@en
A comparison of United Kingdom ...... alues for EQ-5D health states.
@nl
type
label
A comparison of United Kingdom ...... alues for EQ-5D health states.
@en
A comparison of United Kingdom ...... alues for EQ-5D health states.
@nl
prefLabel
A comparison of United Kingdom ...... alues for EQ-5D health states.
@en
A comparison of United Kingdom ...... alues for EQ-5D health states.
@nl
P2093
P2860
P1476
A comparison of United Kingdom ...... alues for EQ-5D health states.
@en
P2093
P2860
P356
10.1177/0272989X0102100102
P577
2001-01-01T00:00:00Z